0QLR.IL
Novartis AG
IOBCHFEQUITY
Healthcare
DELAYED
Last price
127.30
▲ 1.40 (1.11%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
126.86
Prev close
125.90
Day high
0.00
Day low
0.00
Volume
112
Market cap
$287.29B
P/E (TTM)
39.03
52W range
0.00 – 131.50
Day trading desk
Gap from prior close
+0.76%
Prior close 125.90
VWAP
126.00
+1.03% from price
Relative volume
0.82×
Normal
Session range
2.93%
124.04 – 127.68
Position in range
90%
Near session high
ATR (14D)
2.46
1.93% of price
Prior day high
128.16
PDH
Prior day low
125.20
PDL
Bid / ask spread
—
Quote not published
Session volume
995.75K
Avg 1.22M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.67%
+6.0%
1M
+0.96%
-2.8%
3M
+6.03%
+2.9%
6M
+0.24%
-10.8%
YTD
+16.31%
+4.0%
1Y
+23.95%
+4.0%
3Y
+49.69%
-24.5%
5Y
+59.89%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 0QLR.IL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
81.63M
Total on file
Fundamentals
Market cap$287.29B
Enterprise value$192.77B
Revenue (TTM)$53.07B
Gross profit$37.76B
EBITDA$20.03B
Net income$7.65B
EPS (TTM)$3.21
Free cash flow$11.91B
Total cash$11.07B
Total debt$28.34B
Book value / share$25.07
Shares outstanding2.07B
Float1.98B
Short % of float—
Dividend yield3.78%
Beta (5Y)0.49
Valuation & profitability ratios
Trailing P/E39.03
Forward P/E—
PEG ratio—
Price / sales—
Price / book5.00
EV / revenue3.63
EV / EBITDA9.62
Gross margin71.15%
Operating margin27.69%
Profit margin14.41%
Return on equity13.31%
Return on assets7.85%
Debt / equity54.57
Current ratio1.05
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $56.67B | $51.72B | $46.66B | $43.46B | +9.6% |
| Operating revenue | $54.53B | $50.32B | $45.44B | $42.21B | +8.4% |
| Cost of revenue | $13.70B | $12.83B | $12.47B | $11.58B | +6.8% |
| Gross profit | $42.98B | $38.90B | $34.19B | $31.88B | +10.5% |
| Research & development | $11.20B | $10.02B | $11.37B | $9.17B | +11.8% |
| Selling, general & admin | $13.25B | $12.57B | $12.52B | $12.19B | +5.4% |
| Total operating expense | $25.33B | $24.35B | $24.42B | $23.93B | +4.0% |
| Operating income | $17.64B | $14.54B | $9.77B | $7.95B | +21.3% |
| Net interest income | -$980.00M | -$686.00M | -$419.00M | -$574.00M | -42.9% |
| Pre-tax income | $16.35B | $13.64B | $9.12B | $7.18B | +19.9% |
| Tax provision | $2.38B | $1.70B | $551.00M | $1.13B | +40.2% |
| Net income | $13.98B | $11.94B | $14.85B | $6.96B | +17.1% |
| Net income to common | $13.98B | $11.94B | $14.85B | $6.96B | +17.1% |
| Basic EPS | 7.21 | 5.92 | 7.15 | 3.19 | +21.8% |
| Diluted EPS | 7.15 | 5.87 | 7.10 | 3.17 | +21.8% |
| EBIT | $17.50B | $14.65B | $9.98B | $7.98B | +19.5% |
| EBITDA | $22.82B | $20.71B | $18.25B | $14.68B | +10.2% |
| Basic shares | 1.94B | 2.02B | 2.08B | 2.18B | -3.9% |
| Diluted shares | 1.96B | 2.04B | 2.09B | 2.20B | -3.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.44B | $11.46B | $13.39B | $7.52B | — | -0.2% |
| Cash & short-term investments | $11.53B | $13.35B | $13.96B | $18.61B | — | -13.6% |
| Accounts receivable | $8.94B | $7.42B | $7.11B | $8.07B | — | +20.4% |
| Inventory | $6.27B | $5.72B | $5.91B | $7.17B | — | +9.5% |
| Total current assets | $30.46B | $29.70B | $30.48B | $36.91B | — | +2.5% |
| Property, plant & equipment | $12.35B | $10.87B | $10.92B | $12.20B | — | +13.6% |
| Goodwill & intangibles | $54.98B | $51.67B | $50.22B | $60.95B | — | +6.4% |
| Total assets | $110.95B | $102.25B | $99.94B | $117.45B | — | +8.5% |
| Total current liabilities | $27.28B | $28.69B | $26.39B | $28.66B | — | -4.9% |
| Current debt | $5.52B | $8.09B | $6.08B | $5.88B | — | -31.7% |
| Long-term debt | $27.93B | $21.37B | $18.44B | $20.24B | — | +30.7% |
| Total debt | $35.38B | $31.26B | $26.35B | $27.91B | — | +13.2% |
| Total liabilities | $64.40B | $58.12B | $53.20B | $58.03B | — | +10.8% |
| Retained earnings | — | $46.56B | $49.65B | $63.54B | $70.99B | — |
| Shareholder equity | $46.13B | $44.05B | $46.67B | $59.34B | — | +4.7% |
| Working capital | $3.18B | $1.01B | $4.09B | $8.25B | — | +214.4% |
| Net tangible assets | -$8.85B | -$7.63B | -$3.55B | -$1.60B | — | -16.0% |
| Shares issued | 2.11B | 2.19B | 2.28B | 2.40B | — | -3.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $13.97B | $11.94B | $8.57B | $6.05B | +17.0% |
| Depreciation & amortisation | $5.33B | $6.07B | $8.28B | $6.71B | -12.3% |
| Stock-based compensation | $1.10B | $1.04B | $865.00M | $791.00M | +5.0% |
| Change in working capital | -$1.58B | -$706.00M | -$369.00M | -$796.00M | -123.4% |
| Operating cash flow | $19.14B | $17.62B | $14.46B | $14.24B | +8.7% |
| Capital expenditure | -$3.90B | -$3.81B | -$2.75B | -$2.24B | -2.3% |
| Investing cash flow | -$4.88B | -$7.51B | $5.60B | $1.47B | +35.1% |
| Share buybacks | -$9.21B | -$8.33B | -$8.72B | -$10.65B | -10.6% |
| Dividends paid | -$7.82B | -$7.62B | -$7.25B | -$7.51B | -2.5% |
| Financing cash flow | -$14.87B | -$11.74B | -$14.28B | -$20.56B | -26.6% |
| Free cash flow | $15.24B | $13.80B | $11.71B | $12.00B | +10.4% |
| End cash position | $11.44B | $11.46B | $13.39B | $7.52B | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $14.95B | $13.52B | $13.86B | $14.36B | $14.84B | — | +10.6% |
| Operating revenue | $14.41B | $13.11B | $13.34B | $13.91B | $14.05B | — | +9.9% |
| Cost of revenue | $3.71B | $3.46B | $3.61B | $3.54B | $3.32B | — | +7.3% |
| Gross profit | $11.24B | $10.06B | $10.25B | $10.82B | $11.51B | — | +11.7% |
| Research & development | $2.85B | $2.74B | $3.16B | $2.94B | $2.73B | — | +3.9% |
| Selling, general & admin | $3.24B | $3.14B | $3.44B | $3.31B | $3.44B | — | +3.2% |
| Total operating expense | $6.49B | $5.83B | $6.63B | $6.32B | $6.65B | — | +11.3% |
| Operating income | $4.75B | $4.24B | $3.62B | $4.50B | $4.86B | — | +12.2% |
| Net interest income | -$479.00M | -$393.00M | -$96.00M | -$301.00M | -$330.00M | — | -21.9% |
| Pre-tax income | $4.27B | $3.84B | $3.22B | $4.20B | $4.53B | — | +11.2% |
| Tax provision | $1.01B | $683.00M | $814.00M | $266.00M | $507.00M | — | +48.2% |
| Net income | $3.26B | $3.16B | $2.41B | $3.93B | $4.04B | — | +3.4% |
| Net income to common | $3.26B | $3.16B | $2.41B | $3.93B | $4.04B | — | +3.4% |
| Basic EPS | 1.71 | 1.65 | 1.26 | — | 2.07 | 1.83 | +3.6% |
| Diluted EPS | 1.71 | 1.65 | 1.25 | — | 2.06 | 1.82 | +3.6% |
| EBIT | $4.73B | $4.18B | $3.52B | $4.48B | $4.82B | — | +13.1% |
| EBITDA | $6.13B | $5.41B | $5.07B | $5.84B | $6.08B | — | +13.3% |
| Basic shares | 1.91B | 1.91B | 1.91B | — | 1.95B | 1.97B | -0.2% |
| Diluted shares | 1.91B | 1.92B | 1.93B | — | 1.96B | 1.98B | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7.62B | $6.88B | $11.44B | $9.56B | $6.66B | — | +10.7% |
| Cash & short-term investments | $7.69B | $6.98B | $11.53B | $9.75B | $7.00B | — | +10.2% |
| Accounts receivable | $9.64B | $9.39B | $8.94B | $8.84B | $9.06B | — | +2.7% |
| Inventory | $6.22B | $6.29B | $6.27B | $6.42B | $6.31B | — | -1.0% |
| Total current assets | $27.35B | $26.61B | $30.46B | $28.20B | $25.94B | — | +2.8% |
| Property, plant & equipment | $12.27B | $12.24B | $12.35B | $11.99B | $11.83B | — | +0.2% |
| Goodwill & intangibles | $68.84B | $67.03B | $54.98B | $54.59B | $54.79B | — | +2.7% |
| Total assets | $122.03B | $118.53B | $110.95B | $107.29B | $104.39B | — | +3.0% |
| Total current liabilities | $31.75B | $31.37B | $27.28B | $32.00B | $31.71B | — | +1.2% |
| Current debt | $9.59B | $7.62B | $5.52B | $7.52B | $8.31B | — | +25.9% |
| Long-term debt | $37.49B | $37.45B | $27.93B | $22.60B | $22.47B | — | +0.1% |
| Total debt | $49.01B | $47.00B | $35.38B | $32.02B | $32.64B | — | +4.3% |
| Total liabilities | $80.09B | $79.61B | $64.40B | $62.54B | $62.34B | — | +0.6% |
| Retained earnings | $39.65B | $37.25B | — | $43.51B | $41.53B | $39.84B | +6.4% |
| Shareholder equity | $41.54B | $38.51B | $46.13B | $44.33B | $41.98B | — | +7.9% |
| Working capital | -$4.40B | -$4.77B | $3.18B | -$3.80B | -$5.78B | — | +7.8% |
| Net tangible assets | -$27.30B | -$28.52B | -$8.85B | -$10.26B | -$12.81B | — | +4.3% |
| Shares issued | 1.90B | 2.03B | 2.11B | 1.92B | 2.07B | — | -6.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $3.26B | $3.16B | $2.40B | $3.93B | $4.02B | — | +3.2% |
| Depreciation & amortisation | $1.40B | $1.23B | $1.55B | $1.36B | $1.26B | — | +14.0% |
| Stock-based compensation | $267.00M | $303.00M | $299.00M | $268.00M | $267.00M | — | -11.9% |
| Change in working capital | $232.00M | -$787.00M | -$1.59B | $1.34B | $442.00M | — | +129.5% |
| Operating cash flow | $5.88B | $3.68B | $2.26B | $6.57B | $6.66B | — | +60.0% |
| Capital expenditure | -$758.00M | -$807.00M | -$1.02B | -$831.00M | -$558.00M | — | +6.1% |
| Investing cash flow | -$3.10B | -$11.74B | -$2.10B | -$860.00M | -$2.24B | — | +73.5% |
| Share buybacks | -$1.20B | -$1.88B | -$1.48B | -$2.30B | -$2.71B | — | +36.1% |
| Dividends paid | -$2.87B | -$6.20B | $0 | — | -$2.48B | -$5.33B | +53.7% |
| Financing cash flow | -$2.02B | $3.58B | $1.68B | -$2.79B | -$5.21B | — | -156.4% |
| Free cash flow | $5.12B | $2.87B | $1.25B | $5.74B | $6.11B | — | +78.6% |
| End cash position | $7.62B | $6.88B | $11.44B | $9.56B | $6.66B | — | +10.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders3.95%
Held by institutions36.08%
Institutions holding922
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
125.08
+1.78% from price
SMA 20
125.86
+1.14% from price
SMA 50
124.78
+2.02% from price
SMA 100
121.12
+5.11% from price
SMA 200
117.70
+8.15% from price
EMA 12
125.50
+1.43% from price
EMA 26
125.26
+1.63% from price
EMA 50
124.23
+2.47% from price
RSI (14)
55.9
Neutral
MACD (12,26,9)
0.24
Hist 0.07
ATR (14)
2.46
1.93% of price
Realised vol 30D
19.2%
Annualised
Bollinger upper
129.88
20, 2σ
Bollinger lower
121.84
20, 2σ
50 / 200 cross
Golden
124.78 vs 117.70
Trend bias
Above 200
+8.15%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.05
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
19.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-14.0%
Peak to trough
Max drawdown 5Y
-19.4%
Peak to trough
ATR 14
2.46
1.93% of price
Beta (reported)
0.49
5Y monthly, from filing
Dividends & splits
Forward rate$3.20 / yr
Forward yield3.78%
5-year avg yield—
Payout ratio97.31%
Ex-dividend dateMar 9, 2023
Next pay date—
Last split6:5
Split dateOct 4, 2023
Headlines
Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?
Insider Monkey · 6m ago
Dow Jones Futures: Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 9m ago
An $808 monthly payment is reshaping who can afford a new car
TheStreet · 16m ago
UPS Stopped Carrying 2 Million Amazon Packages a Day. Amazon Still Has to Move Them.
Motley Fool · 19m ago
Treasury Market Still Functioning, Fed's Kashkari Says
Bloomberg · 20m ago
Former cricket captains appeal to Pakistan over Khan health care
AFP · 20m ago
3 Growth Stocks That Could Skyrocket in the Second Half of 2026
Motley Fool · 21m ago
Nvidia Notifies Customers About AI-Related Price Hikes
Bloomberg · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.